The clinical research professionals at Celerion have extensive expertise and experience in managing complex early phase studies, across multiple therapeutic areas, helping you to transition through Proof of Concept and beyond. Celerion has helped many customers successfully complete their study by contributing our deep scientific knowledge, therapeutic insight and over 40 years of experience.
Clinically Based Drug Development
As the complexity of clinical studies intensifies, and therapies become more targeted and personal, it is increasingly necessary to have rapid access to bioanalytical capabilities and sample handling to support the clinical development team. Celerion is able to manage complex study designs with unique logistical challenges and sample handling requirement by applying our integrated clinical development capabilities and bioanalytical sciences to a plethora of therapeutic areas and specialty development areas to provide high quality, accelerated results.
Celerion Leadership in Therapeutic Areas
Celerion, a full-service, early clinical CRO, is the leader in accelerating development for Phase I-IIb. Our unique combination of medical expertise, clinical operations experience and scientific excellence, enables you to make timely decisions with expert advice and high-quality data. Our leadership in clinical pharmacology through Proof-of-Concept is focused on helping you translate your science to medicine.
